Lifespan Edge Expands Longevity Care to Florida and Maryland, with Arizona Location Planned

Lifespan Edge, co-founded by futurist John Mauldin and Dr. Michael Roizen, opens two new clinics in West Palm Beach and Columbia to make personalized, evidence-based longevity care more accessible, emphasizing prevention and emerging therapies.

Houston Metrowire Staff
Healthcare
Lifespan Edge Expands Longevity Care to Florida and Maryland, with Arizona Location Planned

Lifespan Edge, a next-generation longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen, has announced the opening of two new locations in West Palm Beach, Florida, and Columbia, Maryland, with a third premier destination planned for Scottsdale, Arizona. The expansion marks a significant step in the company's mission to make personalized, evidence-based longevity care more accessible to individuals seeking to optimize healthspan, cognitive vitality, and quality of life.

Founded in 2024, Lifespan Edge aims to bridge cutting-edge longevity research with individualized clinical care. According to Dr. Michael Roizen, Chair of the Board and Co-Founder, “Healthcare should not begin when disease appears, it should begin decades earlier. Our goal is to help people understand that many of the factors influencing how they age are modifiable.” The new locations include 2528 Okeechobee Blvd. in West Palm Beach, FL, and 10700 Charter Drive, Suite 200 in Columbia, MD, with Scottsdale, Arizona, coming soon as a premier luxury wellness destination.

Each clinic offers a concierge-style experience combining advanced diagnostics, physician-guided evaluations, and personalized strategies focused on prevention, performance, and healthy aging. The expansion reflects a growing consumer demand for proactive approaches to maintaining cognitive function, metabolic health, and physical resilience. John Mauldin, President and Co-Founder, stated, “We founded Lifespan Edge because we saw an opportunity to bring together leading physicians, science-driven medicine, and personalized care under one roof. As longevity research continues to advance, we want our clinics to help translate that science into practical strategies.”

Among the areas of scientific interest is Therapeutic Plasma Exchange (TPE), a procedure being investigated for potential applications in aging and neurodegenerative disease. Notable research includes the AMBAR (Alzheimer Management by Albumin Replacement) clinical trial, which evaluated plasma exchange with albumin replacement in patients with mild-to-moderate Alzheimer’s disease. Published findings reported promise in slowing decline in certain cognitive and functional measures, though additional research is needed. Dr. Roizen commented, “The most exciting developments in longevity are helping us better understand how the body repairs itself and how interventions may support healthier aging.”

Dr. Roizen has long emphasized that biological age and chronological age are not always the same, and that lifestyle choices—including nutrition, physical activity, stress management, purpose, and social connection—can meaningfully influence long-term health. He believes prevention should remain the foundation of modern medicine. “People have more influence over their future health than they often realize,” he said.

With additional locations planned and a continued focus on personalized medicine, Lifespan Edge aims to help redefine aging. The expansion comes amid national recognition for its leadership team, including Dr. Roizen's recent features in Entrepreneur and TopDoctor Magazine, where he discussed his philosophy of persistence, prevention, and personalized care. Lifespan Edge currently operates four locations in Dallas, Texas; Dorado, Puerto Rico; West Palm Beach, Florida; and Columbia, Maryland, with Scottsdale, Arizona, coming soon.

Blockchain Registration

QR Code for Blockchain Registration